Omalizumab Monoclonal Antibody Biosimilars Market to Grow at a CAGR of 7.2% Through 2032 According to a newly published market research report by 24LifeSciences, global omalizumab monoclonal antibody biosimilars market was valued at USD 318 million in 2024 and is projected to reach USD 582 million by 2032, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13928/omalizumab-monoclonal-antibody-biosimilars-market